GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 3151 - 3200 of 40384 in total
PDB ID UniProt ID Title Descriptor ▲
6MK0 P06756 Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161
6MK0 P05106 Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161
6MMB P35439 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1
6MMB Q00959 Diheteromeric NMDA receptor GluN1/GluN2A in the 'Super-Splayed' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 6.1
6MMT P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4
6MMT Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '1-Knuckle' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4
6MMU P35439 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4
6MMU Q00959 Triheteromeric NMDA receptor GluN1/GluN2A/GluN2A* in the '2-Knuckle-Asymmetric' conformation, in complex with glycine and glutamate, in the presence of 1 micromolar zinc chloride, and at pH 7.4
6MU0 P47636 Crystal Structure of Ribose-5-phosphate Isomerase B from Mycoplasma genitalium with bound Ribulose-5-phosphate
6MUF B3UEZ6 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom
6MUF 6MUF Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom
6MUF B3UES2 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom
6N08 H9XIV6 Crystal structure of hemagglutinin from influenza virus A/Netherlands/209/1980 (H3N2)
6N1V 6N1V Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122
6N1V Q2N0S6 Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122
6N4D A0A0H3YBU9 The crystal structure of neuramindase from A/canine/IL/11613/2015 (H3N2) influenza virus.
6N5A A0A348FV55 Crystal structure of an equine H7 hemagglutinin from A/equine/NY/49/73 (H7N7)
6N5B 6N5B Broadly protective antibodies directed to a subdominant influenza hemagglutinin epitope
6N7G Q13635 Cryo-EM structure of tetrameric Ptch1 in complex with ShhNp (form I)
6N7G Q15465 Cryo-EM structure of tetrameric Ptch1 in complex with ShhNp (form I)
6NAE Q05320 Crystal Structure of Ebola zaire GP protein with bound ARN0074898
6NAE 6NAE Crystal Structure of Ebola zaire GP protein with bound ARN0074898
6NAE Q05320 Crystal Structure of Ebola zaire GP protein with bound ARN0074898
6NAE 6NAE Crystal Structure of Ebola zaire GP protein with bound ARN0074898
6NCX A0A1E3AEY6 Crystal structure of GH2 beta-galacturonidase from Eisenbergiella tayi bound to galacturonate
6NF2 Q2N0S6 Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122
6NF2 6NF2 Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122
6NJY F3ZXK6 Type IV CRISPR associated RNA endonuclease Cas6 - apo form
6NLE O67854 X-ray structure of LeuT with V269 deletion
6NM6 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom
6NM6 6NM6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex with Crystallization Chaperones 3H109L Fab and 35O22 scFv at 3.2 Angstrom
6NN9 P03472 REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS
6NP8 Q8PGN7 Xanthomonas citri Phospho-PGM in complex with mannose-6-phosphate
6NRR Q8MRE6 Crystal structure of Dpr11 IG1 bound to DIP-gamma IG+IG2
6NRR Q9VAR6 Crystal structure of Dpr11 IG1 bound to DIP-gamma IG+IG2
6NSC A8W893 Crystal structure of the A/Brisbane/10/2007 (H3N2) influenza virus hemagglutinin G186V/L194P mutant apo form
6NSC A8W891 Crystal structure of the A/Brisbane/10/2007 (H3N2) influenza virus hemagglutinin G186V/L194P mutant apo form
6NWE P02699 Crystal structure of bovine opsin with beta octyl glucoside bound
6NWE 6NWE Crystal structure of bovine opsin with beta octyl glucoside bound
6NWO Q8XMB9 Structures of the transcriptional regulator BgaR, a lactose sensor.
6O8D P10747 Anti-CD28xCD3 CODV Fab bound to CD28
6O8D 6O8D Anti-CD28xCD3 CODV Fab bound to CD28
6ODF E9KXM2 EEEV glycoproteins bound with heparan sulfate
6ODF E9KXL2 EEEV glycoproteins bound with heparan sulfate
6OEU Q13635 Structure of human Patched1
6OPQ B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG
6OPQ B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG
6OPQ P01730 CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG
6OPQ 6OPQ CD4- and 17-bound HIV-1 Env B41 SOSIP frozen with LMNG
6ORP 6ORP Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024